| Mepha Pharma AG - Lisinopril-Mepha 5, Tabletten |
| 56777 | | 01 | | Lisinopril-Mepha 5 | | Tabletten | | C09AA03 | | Lisinopril | | 26.08.2005 | | |
|
| Composition |
| lisinoprilum 5 mg ut lisinoprilum dihydricum, mannitolum, calcii hydrogenophosphas dihydricus, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 1.00 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Lisinopril | 5 mg |
| | | | Inactive agents |
|---|
| Amylum Pregelificatum | | Calcium Hydrogen Phosphate Dihydrate | | Carmellosum Natricum Conexum | | Magnesii Stearas | | Mannitol | | Pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 30 Tablet(s) | 2.42 | 11.85 | B | SL | Yes | | 004 | 100 Tablet(s) | 6.20 | 16.00 | B | SL | Yes |
|
